Bringing New Horizons to Therapy

Management and Board of Directors


Marc Oczachowski / Chief Executive Officer

Marc Oczachowski joined the company in May 1997 as Area Sales Manager, based in Lyon, France. From March 2001 to January 2004, he held management positions as General Manager of EDAP Technomed Malaysia. Previously he worked for Sodem Systems - power tools for orthopedie - as Area Sales Manager. He is a graduate of Institut Commercial de Lyon, France.


Eric Soyer / Chief Financial Officer

Eric Soyer joined the Company in December 2006. He was previously CFO of Medica, a € 270 million French company operating 108 nursing home and post-care clinics throughout France and Italy. Previously he was CFO and a Managing Director of April Group, an insurance services business with 22 subsidiaries in France, the UK, Spain, Germany and Italy. He has international experience as a controller and cost accountant for Michelin Group in France, the United States and Africa. Eric Soyer has degrees from Clermont Management School, the University of Kansas and the HEC Paris School of Management.


Board of Directors

Philippe Chauveau / Independent Director

Chairman of the Board of Directors - Director Since: 1997
In 1997, Philippe Chauveau was named chairman of EDAP-TMS S.A. Supervisory Board, involving a two-tier board structure overseeing an Executive Board. In 2002, both these boards were replaced by a single Board of Directors, which Philippe Chauveau headed as Chairman and CEO. While remaining Chairman of the Board, he was succeeded by Hugues de Bantel, as CEO, in 2004. Philippe Chauveau, since 2000, is also Chairman of the Board of SCYNEXIS Inc., funded by private equity, which is an innovative drug discovery company, based in the USA, partnering with major pharmaceutical companies worldwide. He is also personal executive coach to senior research leaders at HOFFMANN LaROCHE in Switzerland. He was R&D Vice-President at AT&T BELL LABS; he had been Chairman of APPLE COMPUTER Europe, preceded by increasing marketing roles in ITT and in PROCTER & GAMBLE. Philippe Chauveau has a French, Anglo-Irish and American education and culture. He has an Honours Degree from Trinity College Dublin with a BA., and a Bsc.


Marc Oczachowski / Inside Director

Director Since: 2012

Pierre Beysson / Independent Director

Director, Audit Committee Chair - Director Since: 2002
EDAP TMS S.A. Committee Membership: Audit Committee

Pierre Beysson was elected as a member of the Board of Directors in September 2008. Pierre Beysson was then the Chief Financial Officer of Compagnie des Wagons-Lits ("CWC"), the on-board train service division of Accor, a French multinational Hotel and Business Services Group. In this capacity he sat in a number of boards of companies related to the Accor Group. He is now an M&A consultant. Prior to his assignment at CWL, Pierre Beysson has held a number of senior financial positions with Nixdorf Computers, Trane (Air Conditioning), AM International (Office Equipment) and FMC (Petroleum Equipment). His background also includes Industrial Project & Distribution Network Management with Computervision (Computed Aided Design) and Customer Service & Distribution Network Management with Siemens-Nixdorf International. Pierre Beysson was trained as a CPA, has auditing experience and holds an MBA from Havard Business School.

Rob Michiels / Independent Director

Director Since: 2009

EDAP TMS S.A. Committee Membership: Audit Committee

Rob Michiels was elected as a member of the Company's Board of Directors in July 2009. He is a 30-year U.S. veteran of the medical device industry. He currently serves as chief executive officer (CEO) of CardiAQ Valve Technologies, a venture funded start-up developing Transcatheter Mitral Valve Implantation. He previously served as chief operating officer (COO) of CoreValve; and as President and COO of InterVentional Technologies. He helped drive both companies from cardiovascular start-ups to established market leaders, using new and innovative technologies which have strong synergies to the HIFU story. Rob Michiels is a director of CardiAQ Valve Technologies and of Embolization Prevention Technologies, both privately held companies. Rob Michiels is a founding partner of CONSILIUM, a medical device market research company active in identifying, funding and greenhousing start-up technologies. Fluent in English, French and Dutch languages, he holds a bachelor's degree in economics from Antwerp University in Belgium and a Masters in business administration (MBA) from Indiana University.

Dr. Argil Wheelock / Independent Director

Director Since: 2009

EDAP TMS S.A. Committee Membership: Audit Committee
Dr. Argil Wheelock was elected as a member of the Company's Board of Directors in June 2009. Dr. Wheelock, a U.S. board certified urologist, is currently Chief of Urology at Erlanger Medical Center, a tertiary care and teaching hospital in Chattanooga, Tennessee. He is Chief Medical Advisor to HealthTronics Inc., a subsidiary of Endopharmaceuticals, a NASDAQ company. Healtronics is a leading U.S. provider of urological services and products. From 1996 to 2005, Dr. Wheelock served as Chairman and CEO of HealthTronics, a publicly traded NASDAQ company where he was a founder. He has built a successful track record introducing new medical devices to the U.S. and navigating the FDA approval process. He is widely known among the U.S. urological community for bringing clinical benefits to patients and economic value to urology practices. Dr. Wheelock graduated from the University of Tennessee College of Medicine and completed urological training at Mount Sinai Hospital in New York City.



Print This Page